Morgan Stanley’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $947M | Buy |
|
|||||
|
2025
Q1 | $885M | Buy |
|
|||||
|
2024
Q4 | $916M | Buy |
|
|||||
|
2024
Q3 | $792M | Buy |
|
|||||
|
2024
Q2 | $595M | Sell |
|
|||||
|
2024
Q1 | $693M | Sell |
|
|||||
|
2023
Q4 | $959M | Buy |
|
|||||
|
2023
Q3 | $537M | Sell |
|
|||||
|
2023
Q2 | $634M | Sell |
|
|||||
|
2023
Q1 | $618M | Buy |
|
|||||
|
2022
Q4 | $614M | Sell |
|
|||||
|
2022
Q3 | $691M | Sell |
|
|||||
|
2022
Q2 | $702M | Sell |
|
|||||
|
2022
Q1 | $896M | Buy |
|
|||||
|
2021
Q4 | $343M | Sell |
|
|||||
|
2021
Q3 | $417M | Sell |
|
|||||
|
2021
Q2 | $537M | Sell |
|
|||||
|
2021
Q1 | $1.81B | Sell |
|
|||||
|
2020
Q4 | $2.17B | Buy |
|
|||||
|
2020
Q3 | $1.28B | Buy |
|
|||||
|
2020
Q2 | $844M | Sell |
|
|||||
|
2020
Q1 | $697M | Buy |
|
|||||
|
2019
Q4 | $724M | Sell |
|
|||||
|
2019
Q3 | $597M | Sell |
|
|||||
|
2019
Q2 | $816M | Sell |
|
|||||
|
2019
Q1 | $1.08B | Buy |
|
|||||
|
2018
Q4 | $546M | Buy |
|
|||||
|
2018
Q3 | $696M | Sell |
|
|||||
|
2018
Q2 | $911M | Buy |
|
|||||
|
2018
Q1 | $678M | Buy |
|
|||||
|
2017
Q4 | $480M | Sell |
|
|||||
|
2017
Q3 | $501M | Sell |
|
|||||
|
2017
Q2 | $484M | Buy |
|
|||||
|
2017
Q1 | $374M | Buy |
|
|||||
|
2016
Q4 | $272M | Sell |
|
|||||
|
2016
Q3 | $307M | Buy |
|
|||||
|
2016
Q2 | $219M | Sell |
|
|||||
|
2016
Q1 | $346M | Sell |
|
|||||
|
2015
Q4 | $886M | Buy |
|
|||||
|
2015
Q3 | $746M | Buy |
|
|||||
|
2015
Q2 | $563M | Buy |
|
|||||
|
2015
Q1 | $382M | Buy |
|
|||||
|
2014
Q4 | $221M | Sell |
|
|||||
|
2014
Q3 | $221M | Sell |
|
|||||
|
2014
Q2 | $220M | Buy |
|
|||||
|
2014
Q1 | $194M | Buy |
|
|||||
|
2013
Q4 | $176M | Buy |
|
|||||
|
2013
Q3 | $74.5M | Buy |
|
|||||
|
2013
Q2 | $56.7M | Buy |
|